Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Harbin Pharmaceutical Group (600664)
- 3.66
- +0.04+1.10%
Market Closed May 7 15:00 CST
9.22BMarket Cap29.76P/E (TTM)
3.66High3.59Low774.36KlotVolume3.62Open3.62Prev Close281.57MTurnover3.08%Turnover Ratio25.42P/E (Static)2.52BShares4.8852wk High1.57P/B9.22BFloat Cap3.2052wk Low3.98Limit Up2.52BShs Float14.17Historical High3.26Limit Down1.93%Range %-2.06Historical Low--Dividend TTM3.64Avg Price337.46KlotAsk--Div Yield TTM100Lot Size409.43KlotBid
Harbin Pharmaceutical Group (600664) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 13.55%3.18B | -5.44%3.44B | -12.32%2.74B | -3.93%3.05B | -1.58%2.8B | 18.76%3.63B | 13.03%3.13B | 22.51%3.18B | 17.42%2.85B | 25.76%3.06B |
| Notes receivable and accounts receivable | -1.87%4.85B | -0.51%4.4B | -0.98%4.78B | -2.19%4.51B | 3.26%4.94B | -2.00%4.42B | 3.78%4.83B | -0.16%4.61B | 5.28%4.79B | 4.86%4.51B |
| -Notes receivable | -75.27%13.88M | -77.86%13.42M | -55.75%21.21M | -18.29%30.29M | -20.95%56.13M | -25.29%60.63M | -46.99%47.92M | -59.79%37.07M | -66.96%71.01M | -62.33%81.15M |
| -Accounts receivable | -1.03%4.84B | 0.56%4.39B | -0.44%4.76B | -2.06%4.48B | 3.63%4.89B | -1.57%4.36B | 4.78%4.78B | 1.05%4.57B | 8.86%4.72B | 8.40%4.43B |
| Other receivables (including interest and dividends) | -2.96%140.08M | -0.94%129.57M | -15.33%128.76M | -9.14%133.67M | 10.07%144.35M | -10.70%130.8M | 19.27%152.07M | -19.61%147.12M | -18.15%131.14M | -17.95%146.47M |
| -Other receivable | ---- | -0.94%129.57M | ---- | -9.14%133.67M | ---- | -10.70%130.8M | ---- | -19.61%147.12M | ---- | -17.95%146.47M |
| Advance payment | 8.85%239.4M | -22.67%190.07M | 0.49%266.61M | 27.90%302.33M | -2.69%219.93M | 16.48%245.8M | -14.59%265.32M | 21.58%236.39M | -11.69%226.01M | -19.04%211.02M |
| Inventories | 18.42%2.16B | 8.98%2.06B | 7.89%2.08B | -2.72%1.9B | -3.93%1.83B | -1.72%1.89B | 6.66%1.93B | 5.84%1.95B | 9.29%1.9B | 6.66%1.92B |
| Receivable financing | -20.06%383.13M | -38.13%347.68M | 48.74%439.27M | 20.24%493.28M | -5.78%479.26M | 25.61%561.96M | -34.69%295.33M | -4.78%410.26M | -2.99%508.68M | -13.02%447.38M |
| Other current assets | -4.21%79.87M | -4.34%87.69M | 14.48%73.85M | 11.15%74.9M | -0.01%83.38M | -1.75%91.67M | -11.58%64.51M | -12.61%67.38M | 38.60%83.39M | 45.00%93.3M |
| Total current assets | 5.13%11.04B | -2.97%10.65B | -1.40%10.51B | -1.28%10.47B | 0.14%10.5B | 5.60%10.98B | 4.61%10.66B | 6.64%10.6B | 7.96%10.48B | 8.75%10.4B |
| Non Current assets | ||||||||||
| Other equity investment | -7.24%31.06M | -7.24%31.06M | -12.85%33.49M | -12.85%33.49M | -12.85%33.49M | -12.85%33.49M | 2.13%38.42M | 2.13%38.42M | 2.13%38.42M | 2.13%38.42M |
| Investment real estate | 49.35%78.33M | 50.18%80.7M | -5.42%56.81M | -16.90%51.2M | -16.91%52.45M | -16.89%53.74M | 5.62%60.07M | 6.55%61.62M | 33.85%63.12M | 35.08%64.66M |
| Fixed assets | ---- | -0.99%2.2B | ---- | -3.61%2.14B | ---- | -4.21%2.22B | ---- | -6.07%2.22B | ---- | -6.49%2.32B |
| Constru in process | ---- | -12.27%65.56M | ---- | 33.20%97.66M | ---- | 8.11%74.73M | ---- | -8.32%73.32M | ---- | 4.38%69.12M |
| Intangible assets | 1.78%407.58M | 0.77%411.55M | -10.15%389.55M | -9.61%397.66M | -9.42%400.46M | -9.47%408.4M | -0.30%433.55M | -0.80%439.94M | 1.49%442.12M | 1.56%451.14M |
| Development expenditure | 45.52%80.31M | 53.37%76.86M | 78.87%73.85M | 50.72%55.55M | 62.63%55.19M | 84.89%50.11M | -31.84%41.29M | -29.77%36.86M | -36.13%33.93M | -43.01%27.1M |
| Goodwill | 0.00%39.16M | 0.00%39.16M | 0.03%39.16M | 0.03%39.16M | 0.03%39.16M | 0.03%39.16M | 0.00%39.15M | 0.00%39.15M | 0.00%39.15M | 0.00%39.15M |
| Long deferred expense | -14.14%10.49M | -12.17%11.67M | -24.92%9.85M | -22.86%10.72M | 1.04%12.21M | -6.33%13.29M | 0.08%13.12M | -6.82%13.9M | -25.30%12.09M | -13.50%14.19M |
| Deferred tax assets | 1.89%614.33M | 0.68%607.84M | 2.45%608.93M | 1.33%605.34M | 0.71%602.94M | 0.98%603.74M | -0.64%594.34M | -0.56%597.37M | -0.46%598.71M | -0.39%597.85M |
| Usufruct assets | -4.14%79.28M | -17.09%75.43M | -0.37%79.49M | -5.46%78.55M | 13.49%82.7M | 10.31%90.98M | -9.93%79.78M | -15.64%83.09M | -22.27%72.87M | -15.71%82.47M |
| Other non current assets | -31.86%40.26M | -24.96%37.89M | 17.61%50.61M | 57.76%49.39M | 208.08%59.09M | 225.68%50.5M | 4,317.97%43.03M | 3,114.37%31.31M | 1,869.07%19.18M | 1,492.11%15.51M |
| Total non current assets | 0.55%3.61B | -0.07%3.63B | -1.05%3.57B | -2.10%3.56B | -1.84%3.59B | -2.13%3.64B | -3.23%3.61B | -4.07%3.64B | -4.36%3.66B | -4.11%3.72B |
| Total assets | 3.96%14.65B | -2.24%14.29B | -1.31%14.08B | -1.49%14.03B | -0.38%14.09B | 3.57%14.62B | 2.51%14.27B | 3.68%14.24B | 4.47%14.15B | 5.04%14.11B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -11.13%1.02B | -33.04%1.04B | -35.43%1.05B | -39.76%1.11B | -36.45%1.15B | -6.25%1.55B | -10.12%1.62B | 3.63%1.85B | -2.85%1.81B | -14.22%1.66B |
| Notes payable and accounts payable | 7.00%4.23B | -0.17%4.03B | 1.52%3.93B | 1.94%3.85B | 3.43%3.95B | 2.24%4.04B | 1.50%3.87B | -5.00%3.78B | 3.53%3.82B | 12.56%3.95B |
| -Notes payable | -11.44%1.56B | -14.79%1.7B | -3.64%1.52B | 8.92%1.64B | 8.15%1.77B | 19.19%1.99B | 7.89%1.58B | -4.12%1.51B | 26.85%1.63B | 42.49%1.67B |
| -Accounts payable | 21.90%2.67B | 14.03%2.34B | 5.07%2.41B | -2.70%2.21B | -0.09%2.19B | -10.16%2.05B | -2.46%2.3B | -5.58%2.27B | -8.95%2.19B | -2.45%2.28B |
| Contract liabilities | 32.19%106.22M | -59.96%122.01M | -35.45%92.6M | -27.74%82.58M | -49.36%80.35M | 11.19%304.7M | 14.79%143.46M | -21.31%114.28M | 9.21%158.66M | 19.14%274.04M |
| Advance receipts | 16.09%8.1M | 26.36%8.73M | 4.30%7.98M | 9.09%8.12M | 17.63%6.97M | -17.77%6.91M | -11.78%7.65M | -11.87%7.44M | -16.12%5.93M | 43.76%8.41M |
| Salaries payable | -2.26%483.69M | -1.11%566.55M | -0.77%523.46M | -3.05%500.14M | -0.14%494.89M | 1.35%572.9M | 1.00%527.54M | 4.82%515.86M | 3.43%495.57M | 1.42%565.28M |
| Taxs payable | -2.34%137.41M | -21.83%81.82M | -14.03%110.86M | -11.13%102.58M | 1.38%140.7M | -8.59%104.66M | -6.82%128.95M | 6.11%115.42M | -7.64%138.79M | -46.00%114.49M |
| Other payable (including interest and dividends) | 6.33%1.42B | 6.73%1.35B | -1.20%1.36B | -2.82%1.41B | -7.54%1.33B | -10.30%1.27B | -7.43%1.37B | 10.40%1.45B | 8.92%1.44B | 14.02%1.41B |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --21.02M | ---- | ---- |
| -Other payable | ---- | 6.73%1.35B | ---- | -1.39%1.41B | ---- | -10.30%1.27B | ---- | 8.79%1.43B | ---- | 14.02%1.41B |
| Non current liabilities due within one year | -0.78%139.29M | -5.22%140.67M | -2.61%139.79M | 2.05%140.23M | 0.41%140.38M | 3.85%148.42M | -0.66%143.54M | -3.92%137.41M | 7.52%139.81M | -2.93%142.92M |
| Other current liabilities | -8.41%65.48M | -27.86%76.52M | -1.19%66.26M | -3.36%62.37M | -13.15%71.49M | -8.52%106.07M | -42.78%67.06M | -45.32%64.55M | -51.22%82.32M | -30.55%115.95M |
| Total current liabilities | 3.24%7.61B | -8.42%7.42B | -7.73%7.28B | -9.47%7.27B | -8.93%7.37B | -1.67%8.11B | -3.35%7.89B | -0.73%8.03B | 1.71%8.09B | 3.01%8.24B |
| Current liabilities | ||||||||||
| Long term loan | -1.40%31.48M | -0.71%31.48M | -2.92%31.93M | -1.62%32.14M | -2.82%31.92M | -2.83%31.7M | -1.56%32.89M | -1.57%32.67M | -1.68%32.85M | -1.69%32.63M |
| Long term salaries pay | -12.92%41.78M | -12.92%41.78M | -15.03%47.98M | -15.04%47.98M | -15.27%47.98M | -15.28%47.98M | -18.89%56.47M | -18.91%56.48M | -18.72%56.63M | -18.75%56.64M |
| Estimate liabilities | --997.76K | --997.76K | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | 26.61%7.24M | 32.39%7.59M | -30.10%6.58M | -29.79%6.61M | -17.26%5.72M | -17.07%5.73M | 215.12%9.42M | 215.12%9.42M | 131.28%6.91M | 9.95%6.91M |
| Long term deferred income | 0.57%296.53M | -3.25%290.97M | -9.22%283.17M | -8.43%290.86M | -8.73%294.84M | -5.75%300.74M | -1.63%311.92M | -1.82%317.64M | -1.72%323.05M | -4.36%319.07M |
| Lease liabilities | -16.83%27.91M | -14.61%30.16M | 23.68%27.43M | -6.98%29.25M | 71.43%33.55M | 13.65%35.32M | -33.58%22.18M | -27.72%31.44M | -64.19%19.57M | -28.85%31.08M |
| Total non current liabilities | -1.95%405.94M | -4.39%402.98M | -8.27%397.1M | -9.12%406.85M | -5.69%414.01M | -5.57%421.48M | -5.17%432.88M | -5.33%447.65M | -10.30%439.01M | -8.25%446.33M |
| Total liabilities | 2.96%8.02B | -8.22%7.83B | -7.75%7.67B | -9.46%7.67B | -8.76%7.79B | -1.87%8.53B | -3.45%8.32B | -0.98%8.48B | 1.01%8.53B | 2.37%8.69B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%2.52B | 0.00%2.52B | 0.00%2.52B | -0.11%2.52B | -0.11%2.52B | -0.11%2.52B | -0.10%2.52B | -0.12%2.52B | -0.10%2.52B | -0.18%2.52B |
| Capital reserve funds | -1.46%674.09M | -3.04%663.33M | -3.04%663.33M | -0.18%684.11M | -0.18%684.11M | -0.18%684.11M | -0.73%684.11M | -0.76%685.32M | -0.40%685.32M | -0.48%685.32M |
| Surplus reserve funds | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B |
| Retained profit | 10.92%3.15B | 13.77%2.99B | 18.93%2.95B | 24.42%2.89B | 30.60%2.84B | 31.50%2.63B | 31.06%2.48B | 29.74%2.32B | 25.84%2.17B | 24.68%2B |
| Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -58.70%3.98M | -58.70%3.98M | -69.40%3.98M |
| Other composite income | -0.14%-1.77B | -0.14%-1.77B | -0.19%-1.76B | -0.13%-1.76B | -0.18%-1.76B | -0.18%-1.76B | 0.09%-1.76B | 0.05%-1.76B | -0.06%-1.76B | 0.00%-1.76B |
| Shareholders equity without minority interests | 5.34%5.86B | 6.32%5.69B | 8.56%5.66B | 11.18%5.61B | 13.51%5.56B | 13.24%5.35B | 12.70%5.21B | 11.73%5.05B | 10.00%4.9B | 9.16%4.72B |
| Minority interests | 4.13%776.08M | 4.67%774M | 1.59%749.92M | 3.50%743.66M | 4.63%745.28M | 5.83%739.49M | 8.79%738.21M | 9.10%718.52M | 11.70%712.32M | 12.91%698.75M |
| Total shareholder equity | 5.20%6.64B | 6.12%6.46B | 7.69%6.41B | 10.22%6.35B | 12.38%6.31B | 12.29%6.09B | 12.20%5.95B | 11.39%5.76B | 10.21%5.61B | 9.63%5.42B |
| Total liabilityies and equity | 3.96%14.65B | -2.24%14.29B | -1.31%14.08B | -1.49%14.03B | -0.38%14.09B | 3.57%14.62B | 2.51%14.27B | 3.68%14.24B | 4.47%14.15B | 5.04%14.11B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | CICC TianTong Certified Public Accountants (Special General Partnership) | -- | -- | -- | CICC TianTong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Beijing Xinghua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm